Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-02-28
1992-02-11
Shen, Cecilia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514252, 514253, 544360, 544364, 544396, 544398, 544403, A61K 31495, C07D29508
Patent
active
050876279
ABSTRACT:
A method for treatment of disorders of the cerebro-neural transmission system which comprises administering a compound of the formula (I) or a pharmaceutically acceptable salt thereof in a therapeutically effective amount, either alone or in admixture with one or more pharmaceutically acceptable excipients, ##STR1## wherein Ar or Ar' is unsubstituted or substituted phenyl or pyridyl; R is hydrogen, lower alkyl, lower alkoxy, halogen or lower alkylenedioxy; A is C.sub.1 -C.sub.6 alkylene; and n is 0 or 1. A compound of the formula (II) or a pharmaceutically acceptable salt thereof, ##STR2## wherein R.sup.1 is hydrogen or fluorine; R.sup.2 is hydrogen or fluorine; R.sup.3 is hydrogen, lower alkyl, lower alkoxy, halogen or lower alkylenedioxy; A is lower C.sub.1 -C.sub.6 alkylene, and n is 0 or 1, provided that at least one of R.sup.1 or R.sup.2 is fluorine.
REFERENCES:
patent: 3957788 (1976-05-01), Nishimura et al.
patent: 4265894 (1981-05-01), Gootjes
patent: 4656175 (1987-04-01), Bjork et al.
patent: 4757074 (1988-07-01), Coker et al.
R. P. Shank et al., "Preclinical Evaluation of McN-5707 as a Potential Antidepressant", J. Pharm. Exp. Ther., vol. 242, No. 1, pp. 74-84.
C. Idzikowski et al., "5-Hydroxytryptamine-2 antagonist increases human slow wave sleep", Brain Research, 378 (1986), pp. 164-168.
Irwin Lucki et al., "Differential Actions of Serotonin Antagonists on Two Behavioral Models of Serotonin Receptor Activation in the Rat", J. Pharm. Exp. Ther., vol. 228, (1984) pp. 133-139.
Nishimura et al., Chemical Abstract, 109579j, vol. 89 (1978) p. 932.
Iwao et al., Chemical Abstract, 149568t, vol. 109 (1988), p. 742.
Iso Tadashi
Morita Takakazu
Yamauchi Hideyasu
Santen Pharmaceutical Co. Ltd.
Shen Cecilia
LandOfFree
Agent for treatment of disorders of the cerebro-neural transmiss does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Agent for treatment of disorders of the cerebro-neural transmiss, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for treatment of disorders of the cerebro-neural transmiss will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-782044